Accelus Stock

integrityimplants.comHealthcare / Medical DevicesFounded: 2016Funding to Date: $178.4MM

Accelus (formerly Integrity Implants) develops and manufactures medical implants used in spinal surgery.

Register To Buy and Sell Shares

For more details on financing and valuation for Accelus, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Accelus’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Accelus.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Accelus’ stock FAQs


Can you buy Accelus’ stock?

Accelus is not publicly traded on NYSE or NASDAQ in the U.S. To buy Accelus’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Accelus’ stock?

Yes, you can sell stock of a private company like Accelus. Forge can help you sell your Accelus stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Accelus’ stock price?

Accelus is a privately held company and therefore does not have a public stock price. However, you may access Accelus’ private market stock price with Forge Data.

What is Accelus’ stock ticker symbol?

Accelus does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Alphatec nabs Fusion Robotics’ REMI system for $55M

Alphatec Holdings has purchased the robotic-enabled minimally invasive (REMI) system from Fusion Robotics for $55 million in cash. The REMI system allows for precise guidance of instruments and implants during spine surgery, aligning with Alphatec's focus on spinal surgery solutions. The acquisition will aid Alphatec's expansion in sophisticated navigation systems for spine procedures.

FDA clears Remi robot from Accelus for use with most spine surgery imaging systems

The FDA has granted 510(k) clearance to Accelus for its Remi robotic navigation system for use with GE OEC 9900 C-Arm fluoroscopic imaging systems. The system, designed for robotic targeting and navigation, assists surgeons with robotic-assisted pedicle screw placement in the lumbar spine. It can run in multiple rooms for multiple procedures in a given day and is expected to begin initial 2D surgeries in July, with a full commercial launch planned for late Q3 2023.
Updated on: Jul 17, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.